Heal Capital
VC Fund
Berlin, Germany
Heal Capital is a VC fund in Berlin focused on Health Care and Artificial Intelligence. Heal Capital is one of Europe’s leading dedicated investment funds for HealthTech with a total investment volume of over EUR 200m, backed by the healthcare institutions We back mission-driven founders with capital and HealthTech-specific expertise, accelerating market access to the healthcare system. Our investment focus is pre-seed to Series A.
- Total investments:
- 52
- Last investment:
- Lead investor:
- 52%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Heal Capital invests in
Stages Heal Capital invests in
Countries Heal Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Seed
- $1M–$12M
- Pre-Seed
- $1.9M–$4M
- Series A
- $9M–$35M
Investment Focus
Industry
- Health Care 20 (38%)
- Artificial Intelligence 10 (19%)
- Software 5 (10%)
- Machine Learning 5 (10%)
- Medical 4 (8%)
Stage
- Seed 17 (33%)
- Series A 11 (21%)
- Pre-Seed 5 (10%)
- Series B 3 (6%)
- Convertible Note 1 (2%)
Country
- Germany 11 (21%)
- United Kingdom 5 (10%)
- France 3 (6%)
- Switzerland 2 (4%)
- United States 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Eckhardt Weber
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 19 | Find email | |
Christian Lautner
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
Lucas Mittelmeier
Investment Professional
|
Investment Professional | Total investments: 2 | Find email | |
Markus Müschenich
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
Marta Michniewicz
Platform Manager
|
Platform Manager | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Vocca provides AI powered voice agents for healthcare centers to handle calls, bookings, and reminders, improving the patient experience. | $20M / Series A / Oct 06, 2026 | ||
| Aitiologic is an Austrian precision medicine firm that creates AI-powered solutions for early disease identification and tailored therapy. | $7.4M / Seed / Sep 15, 2026 | ||
| Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology. | Seed / Jun 09, 2026 | ||
| Ditto is a health tech company that offers a platform for healthcare communication and organization. | $8.9M / Seed / May 12, 2026 | ||
| Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging. | $23M / Series A / Apr 29, 2026 | ||
| FormlyAI is a specialized AI-powered software platform that simplifies and streamlines medical device certification and compliance, with a focus on startups and smaller firms. | $2M / Seed / Sep 11, 2025 | ||
| A technology-enabled provider of children's mental health services, starting with autism assessments. | $4M / Pre-Seed / Jul 15, 2025 | ||
| MediShout is a digital platform to improve operational efficiencies, so healthcare staff can focus on patient care. MediShout brings calmness to chaotic wards and turns hospitals into smart and automated buildings. Our technology connects staff, systems, machines, and work-flow; thus improving efficiency and care. Our cloud-based technologyconnects people, Helpdesks, smartphones, tablets, IT systems, and RFID tagging. | $9M / Series A / Jul 02, 2025 | ||
| At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10million patients with metastatic cancer. Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed. | $1.9M / Pre-Seed / Apr 14, 2025 | ||
| apheris AI was founded by Robin Rohm and Michael Höh with a shared dream to empower companies to run analytics on decentralized datasets. Michael developed software infrastructure for distributed data during his PhD at Forschungszentrum Julich and his time at BCG. Robin has a background in algebraic theories for data linkage and data privacy andhas experienced the complexity of centralizing sensitive personal healthcare data firsthand in one of his previous start-ups. Through their work, they encountered barriers that limit progress within data driven industries: data is often stored in silos and most companies work in closed data ecosystems. Therefore, Apheris strives to connect the world’s data to extract better insights. | $20.8M / Series A / Jan 02, 2025 | ||
| See all 52 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Heal Capital invest in?
Heal Capital invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 52 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Heal Capital invest in?
Heal Capital typically joins rounds of $1M–$12M at Seed, $1.9M–$4M at Pre-Seed and $9M–$35M at Series A. These are whole funding-round sizes, not Heal Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Heal Capital took part in.
How do I contact Heal Capital?
Public channels for Heal Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Heal Capital?
The team at Heal Capital includes Eckhardt Weber (Co-Founder and Managing Partner), Christian Lautner (Managing Partner) and Lucas Mittelmeier (Investment Professional), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
